brentuximab vedotin

E2049899 UNEXPLORED

Brentuximab vedotin is an antibody-drug conjugate used primarily to treat certain CD30-positive lymphomas, including Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (2)

Label	Occurrences
Adcetris	1
brentuximab vedotin canonical	1

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Seagen → hasTherapy → brentuximab vedotin ⓘ

Seagen → developed → Adcetris ⓘ

linked to: brentuximab vedotin